يعرض 1 - 10 نتائج من 359 نتيجة بحث عن '"Villarreal Laura"', وقت الاستعلام: 1.09s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المؤلفون: Villarreal, Laura Noemí

    المصدر: Antología Concurso Literario USAL en Lengua Inglesa; Antología Concurso Literario USAL en Lengua Inglesa. 2022. ; 2618-4524

    وصف الملف: application/pdf

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    وصف الملف: 7 páginas; application/pdf

    العلاقة: Value in Health Regional Issues; 1. Sebbag E, Felten R, Sagez F, Sibilia J, Devilliers H, Arnaud L. The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database. Ann Rheum Dis. 2019;78(6):844–848.; 2. Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1316–1322.; 3. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [published correction appears in Lancet. 2019;393(10190):e44]. Lancet. 2018;392(10159):1789–1858.; 4. Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390(10089): 73–84.; 5. Strand V, Singh JA. Patient burden of axial spondyloarthritis. J Clin Rheumatol. 2017;23(7):383–391.; 6. Rohde G, Hansen BK, Prøven A, Haugeberg G. The relationship between demographic- and disease-related variables and health-related quality of life in patients with axial spondyloarthritis. BMC Musculoskelet Disord. 2017;18(1):328.; 7. López-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A. Characteristics and burden of disease in patients with radiographic and nonradiographic axial spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019;5(2):e001108.; 8. Kwan YH, Kwoh SY, Phang JK, et al. The direct and indirect costs of axial spondyloarthritis (axSpA) in Singapore. Int J Rheum Dis. 2020;23(3): 334–341.; 9. MachadoMAdÁ, Ferre F, deMoura CS, et al. Costs of drug therapyin patientswith ankylosing spondylitis in Brazil. Rheumatol Ther. 2016;3(2):353–361.; 11. Akkoç N, Direskeneli H, Erdem H, et al. Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in Turkey. Rheumatol Int. 2015;35(9):1473–1478.; 12. Krüger K, von Hinüber U, Meier F, et al. Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis. Rheumatol Int. 2018;38(11):2121–2131.; 13. Reveille JD, Ximenes A, Ward MM. Economic considerations of the treatment of ankylosing spondylitis. Am J Med Sci. 2012;343(5):371–374.; 14. Malaviya A. Classification of spondyloarthritis: a journey well worth. Indian J Rheumatol. 2013;8(3):122–129.; 15. Yi E, Ahuja A, Rajput T, George AT, Park Y. Clinical, economic, and humanistic burden associated with delayed diagnosis of axial spondyloarthritis: a systematic review. Rheumatol Ther. 2020;7(1):65–87.; 16. Rocha FAC. Latin-American challenges and opportunities in rheumatology. Arthritis Res Ther. 2017;19(1):29.; 17. Brenol CV, Ivan J, Nava G, Soriano ER. Proper management of rheumatoid arthritis in Latin America. What the guidelines say? [published correction appears in Clin Rheumatol. 2015;34(suppl 1):S57]. Clin Rheumatol. 2015;34(suppl 1):S51–S55.; 18. Colombia - Régimen subsidiado del sistema general de seguridad social en salud de Colombia - Serie de estudios ÚNICO. Banco Mundial. https:// openknowledge.worldbank.org/handle/10986/13285. Accessed June 5, 2022.; 19. Guerrero MC R, Gallego AI, Becerril-Montekio V, et al. Sistema de salud de Colombia. Salud Publ Mex. 2011;53(suppl 2):S144–S155.; 20. Acceso a servicios de salud en Colombia. Décimo primer Informe Técnico Bogotá. Instituto Nacional de Salud. Observatorio Nacional de Salud. https:// www.ins.gov.co/Direcciones/ONS/Resumenes%20Ejecutivos/Resumen%20ej ecutivo%20informe%2011%20acceso%20a%20servicios%20en%20salud%20en %20Colombia.pdf. Accessed June 5, 2022.; 21. Comportamiento del aseguramiento. Ministerio de Salud y Protección Social. https://www.minsalud.gov.co/proteccionsocial/Regimensubsidiado/PaginasTest/ coberturas-del-regimen-subsidiado.aspx. Accessed May 21, 2020.; 22. Lindström U, Bremander A, Bergman S, Haglund E, Petersson IF, Jacobsson LT. SAT0253 patients with non-as axial SPA have similar prevalence compared to as, but worse perceived health. Results from a population based study. Ann Rheum Dis. 2013;72(suppl 3):A667-A668. https://ard.bmj.com/content/72Test/ Suppl_3/A667.3. Accessed June 5, 2022.; 23. Jovani V, Loza E, García de Yébenes MJ, et al. Variability in resource consumption in patients with spondyloarthritis in Spain. Preliminary descriptive data from the emAR II study. ReumatolClin. 2012;8:114–119.; 24. SISMED, Sistema de Información de Precios de Medicamentos. Ministerio de Salud y Protección Social. https://www.sispro.gov.co/central-prestadores-deservicios/Pages/SISMED-Sistema-de-Informacion-de-Precios-de-MedicamentosTest. aspx. Accessed June 5, 2022.; 25. Manual para la elaboración de evaluaciones económicas en salud. Instituto de Evaluación Tecnológica en Salud-IETS. http://www.iets.org.coTest/ Archivos/64/Manual_evaluacion_economica.pdf. Accessed June 5, 2022.; 26. Santos-Moreno P, Gómez-De la Rosa F, Parra-Padilla D, et al. Frequency of health care resource utilization and direct medical costs associated with psoriatic arthritisin a Rheumatic Care Centerin Colombia. Psoriasis (Auckl). 2021;11:31–39.; 27. Acuerdo No. 256 de 2001 - manual de tarifas de la entidad promotora de salud del seguro social. Ministerio de Salud y Protección Social. https:// lexsaludcolombia.files.wordpress.com/2010/10/tarifas-iss-2001.pdf. Accessed June 6, 2022.; 28. Tasa representativa del mercado (TRM - Peso por dólar). Banco de la República, Colombia. https://www.banrep.gov.co/es/estadisticas/trmTest. Accessed February 12, 2021.; 29. Ramsey SD, Willke RJ, Glick H, et al. Cost-effectiveness analysis alongside clinical trials II—an ISPOR good research practices task force report. Value Health. 2015;18(2):161–172.; 30. Mihaylova B, Briggs A, O’Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20(8):897–916.; 31. Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy. 2004;9(4):197–204.; 32. Azevedo VF, Rossetto CN, Lorencetti PG, Tramontin MY, Fornazari B, Araújo DV. Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health system. Rev Bras Reumatol Engl Ed. 2016;56(2):131–137.; 33. Fitzgerald GE, Maguire S, Lopez-Medina C, Dougados M, O’Shea FD, Haroon N. Tender to touch - prevalence and impact of concomitant fibromyalgia and enthesitis in spondyloarthritis: an ancillary analysis of the ASAS PerSpA study. Joint Bone Spine. 2022;89(6):105420.; 34. Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology (Oxford). 2020;59(suppl 4):iv47–iv57.; 35. Puche-Larrubia MÁ, Ladehesa-Pineda L, Font-Ugalde P, et al. Distribution of comorbidities in spondyloarthritis with regard to the phenotype and psoriasis: data from the ASAS-COMOSPA study. Ther Adv Musculoskelet Dis. 2021;13:1759720X211045263.; 36. Westhovens R, Annemans L. Costs of drugs for treatment of rheumatic diseases. RMD Open. 2016;2(2):e000259.; 94; 88; 32; https://hdl.handle.net/11323/10763Test; Corporación Universidad de la Costa; REDICUC – Repositorio CUC; https://repositorio.cuc.edu.coTest/

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
  10. 10
    دورية أكاديمية

    المصدر: ClinicoEconomics and Outcomes Research ; https://pubmed.ncbi.nlm.nih.gov/34168469Test/

    وصف الملف: application/pdf

    العلاقة: Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584; Nordberg LB, Lillegraven S, Aga AB, et al. Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial. RMD Open. 2018;4(2):e000752. doi:10.1136/rmdopen-2018-000752; Ostergaard M, Pedersen SJ, Dohn UM. Imaging in rheumatoid arthritis- status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography. Best Pract Res Clin Rheumatol. 2008;22(6):1019–1044. doi:10.1016/j.berh.2008.09.014; Pratt AG, Isaacs JD. Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspects. Best Pract Res Clin Rheumatol. 2014;28(4):651–659. doi:10.1016/j.berh.2014.10.016; Vasanth LC, Pavlov H, Bykerk V. Imaging of rheumatoid arthritis. Rheum Dis Clin North Am. 2013;39(3):547–566. doi:10.1016/j.rdc.2013.03.007; Ostergaard M, Peterfy CG, Bird P, et al. The OMERACT rheumatoid arthritis magnetic resonance imaging (MRI) scoring system: updated recommendations by the OMERACT MRI in arthritis working group. J Rheumatol. 2017;44(11):1706–1712. doi:10.3899/jrheum.161433; Szkudlarek M, Terslev L, Wakefield RJ, et al. Summary findings of a systematic literature review of the ultrasound assessment of bone erosions in rheumatoid arthritis. J Rheumatol. 2016;43(1):12–21. doi:10.3899/jrheum.141416; Ostergaard M, Ejbjerg B, Szkudlarek M. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Best Pract Res Clin Rheumatol. 2005;19(1):91–116. doi:10.1016/j.berh.2004.08.006; Rudwaleit M, van der Heijde D, Landewe R, et al. The development of assessment of spondyloarthritis international society slassification criteria for axial spondyloarthritis (Part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–783. doi:10.1136/ard.2009.108233; Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–1159. doi:10.1136/annrheumdis-2018-214819; Shiboski CH, Shiboski SC, Seror R, et al. 2016 American college of rheumatology/European league against rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9–16. doi:10.1136/annrheumdis-2016-210571; Wakefield RJ, Balint PV, Szkudlarek M, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32(12):2485–2487.; Terslev L, Naredo E, Aegerter P, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce- part 2: reliability and application to multiple joints of a standardised consensus-based scoring system. RMD Open. 2017;3(1):e000427. doi:10.1136/rmdopen-2016-000427; Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Ostergaard M. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum. 2003;48(4):955–962. doi:10.1002/art.10877; England BR, Tiong BK, Bergman MJ, et al. 2019 Update of the American college of rheumatology recommended rheumatoid arthritis disease activity measures. Arthritis Care Res. 2019;71(12):1540–1555. doi:10.1002/acr.24042; Smolen JS, Landewe R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960–977. doi:10.1136/annrheumdis-2016-210715; Hochberg MC, Altman RD, April KT, et al. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465–474. doi:10.1002/acr.21596; Rausch Osthoff AK, Niedermann K, Braun J, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77(9):1251–1260. doi:10.1136/annrheumdis-2018-213585; Instituto de Evaluación Tecnológica en Salud. Manual para la elaboración de evaluaciones económicas en salud. Bogotá, D.C: IETS; 2014.; Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Int J Technol Assess Health Care. 2013;29(2):117–122. doi:10.1017/s0266462313000160; Minsalud. SISMED - Sistema de Información de Precios de Medicamentos Ministerio Colombiano de Salud y Protección Social. 2019. Available from: https://www.sispro.gov.co/central-prestadores-de-servicios/Pages/SISMEDTest-. Accessed July8, 2019.; Miles KA. Cancer imaging: is it cost-effective? Cancer Imaging. 2004;4(2):97–103. doi:10.1102/1470-7330.2004.0017; Rezaei H, Torp-Pedersen S, Af Klint E, et al. Diagnostic utility of musculoskeletal ultrasound in patients with suspected arthritis- a probabilistic approach. Arthritis Res Ther. 2014;16(5):448. doi:10.1186/s13075-014-0448-6; Jeka S, Dura M, Zuchowski P, Zwierko B, Waszczak-Jeka M. The role of ultrasonography in the diagnostic criteria for rheumatoid arthritis and monitoring its therapeutic efficacy. Adv Clinical Exp Med. 2018;27(9):1303–1307. doi:10.17219/acem/69133; Colebatch AN, Edwards CJ, Ostergaard M, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72(6):804–814. doi:10.1136/annrheumdis-2012-203158; Ventura-Ríos L, Hernández-Díaz C, Sánchez-Bringas G, Madrigal-Santillán E, Morales-González JA, Pineda C. A descriptive, cross-sectional study characterizing bone erosions in rheumatoid arthritis and gout by ultrasound. Clin Rheumatol. 2016;35(9):2269–2276. doi:10.1007/s10067-016-3338-2; Sahatciu-Meka V, Rexhepi S, Manxhuka-Kerliu S, Rexhepi M. Radiographic estimation in seropositive and seronegative rheumatoid arthritis. Bosn J Basic Med Sci. 2011;11(3):180–184. doi:10.17305/bjbms.2011.2571; Chan KW, Felson DT, Yood RA, Walker AM. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum. 1994;37(6):814–820. doi:10.1002/art.1780370606; Bird P, Conaghan P, Ejbjerg B, et al. The development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis. 2005;64(Suppl 1):i8–i10. doi:10.1136/ard.2004.031807; Duer-Jensen A, Horslev-Petersen K, Hetland ML, et al. Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis Rheum. 2011;63(8):2192–2202. doi:10.1002/art.30396; Sugimoto H, Takeda A, Hyodoh K. Early-stage rheumatoid arthritis: prospective study of the effectiveness of MR imaging for diagnosis. Radiology. 2000;216(2):569–575. doi:10.1148/radiology.216.2.r00au20569; Nieuwenhuis WP, Krabben A, Stomp W, et al. Evaluation of magnetic resonance imaging-detected tenosynovitis in the hand and wrist in early arthritis. Arthritis Rheumatol. 2015;67(4):869–876. doi:10.1002/art.39000; Machado PM, Koevoets R, Bombardier C, van der Heijde DM. The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: a systematic review. J Rheumatol. 2011;87:31–37. doi:10.3899/jrheum.101072; Narváez J, Sirvent E, Narváez JA, et al. Usefulness of magnetic resonance imaging of the hand versus anticyclic citrullinated peptide antibody testing to confirm the diagnosis of clinically suspected early rheumatoid arthritis in the absence of rheumatoid factor and radiographic erosions. Semin Arthritis Rheum. 2008;38(2):101–109. doi:10.1016/j.semarthrit.2007.10.012; Buisman LR, Luime JJ, Oppe M, Hazes JMW, Rutten-van Molken MP. A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):135. doi:10.1186/s13075-016-1020-3; https://hdl.handle.net/11323/8624Test; https://doi.org/10.2147/CEOR.S302404Test; Corporación Universidad de la Costa; REDICUC - Repositorio CUC; https://repositorio.cuc.edu.coTest/